These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29235399)

  • 21. [Ventricular assist devices as bridge to heart transplantation in cardiogenic shock or terminal heart failure--12 years experience at the Sheba Medical Center].
    Lavee J; Kassif Y; Freimark D; Har Zahav Y; Koman V; Preisman S; Smolinsky A; Raanani E
    Harefuah; 2007 Nov; 146(11):833-6, 911. PubMed ID: 18087826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
    Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
    Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation.
    Nativi JN; Drakos SG; Kucheryavaya AY; Edwards LB; Selzman CH; Taylor DO; Hertz MI; Kfoury AG; Stehlik J
    J Heart Lung Transplant; 2011 Aug; 30(8):854-61. PubMed ID: 21571550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes.
    Gustafsson F; Rogers JG
    Eur J Heart Fail; 2017 May; 19(5):595-602. PubMed ID: 28198133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional and haemodynamic recovery after implantation of continuous-flow left ventricular assist devices in comparison with pulsatile left ventricular assist devices in patients with end-stage heart failure.
    Pruijsten RV; Lok SI; Kirkels HH; Klöpping C; Lahpor JR; de Jonge N
    Eur J Heart Fail; 2012 Mar; 14(3):319-25. PubMed ID: 22294758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal disease.
    Grupper A; Park SJ; Pereira NL; Schettle SD; Gerber Y; Topilsky Y; Edwards BS; Daly RC; Stulak JM; Joyce LD; Kushwaha SS
    J Heart Lung Transplant; 2015 Aug; 34(8):1042-9. PubMed ID: 25940074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular Assist Device Therapy in Older Patients With Heart Failure: Characteristics and Outcomes.
    Kim JH; Singh R; Pagani FD; Desai SS; Haglund NA; Dunlay SM; Maltais S; Aaronson KD; Stulak JM; Davis ME; Salerno CT; Cowger JA; Shah P;
    J Card Fail; 2016 Dec; 22(12):981-987. PubMed ID: 27765670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Permanent mechanical circulatory support in patients of advanced age.
    Jurmann MJ; Weng Y; Drews T; Pasic M; Hennig E; Hetzer R
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):610-8. PubMed ID: 15037280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantation of the continuous flow HeartWare® left ventricular assist device.
    Carrel T; Englberger L; Kadner A; Mohacsi P
    Multimed Man Cardiothorac Surg; 2013; 2013():mmt010. PubMed ID: 24413008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
    Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
    J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Zuckermann AO; Wieselthaler GM
    J Heart Lung Transplant; 2009 Apr; 28(4):367-72. PubMed ID: 19332264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.
    Kimura M; Kinoshita O; Nawata K; Nishimura T; Hatano M; Imamura T; Endo M; Kagami Y; Kubo H; Kashiwa K; Kinugawa K; Kyo S; Komuro I; Ono M
    J Cardiol; 2015 May; 65(5):383-9. PubMed ID: 25034705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The current era of left ventricular assist devices.
    Javorski MJ; Zaki A; Abas M; Elgharably H; Attia TS
    Future Cardiol; 2021 Sep; 17(6):971-984. PubMed ID: 33563033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.